Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer

Acta Urologica Japonica

Volumn 44, Issue 9, 1998, Pages 639-643

  Meguro, Norio ^a   Maeda, Osamu ^a   Saiki, Shigeru ^a   Kinouchi, Toshiaki ^a   Kuroda, Masao ^a   Usami, Michiyuki ^a   Kotake, Toshihiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

PSA; PSAD; T1a; T1b Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 2442670677     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fowler JE, Pandey P, Bigler SA, et al. : Trends in diagnosis of stage T1A-B prostate cancer. J Urol 158 : 1849-1852, 1997
2. Sobin LH and Wittekind C : International Union Against Cancer. TNM classification of malignant tumors. 5th edition, 170-173, 1997
3. Hodge KK, McNeal SF, Terris MK, et al.: Random systematic versus directed ultrasoundguided transrectal core biopsies of the prostate. J Urol 142 : 71-74, 1989
4. Abu-Yousef MM and Narayama AS: Transabdominal ultrasound in the evaluation of prostate size. JCU J Clin Ultrasound 10 : 275-278, 1982
5. Monda JM, Barry MJ and Oesterling JE : Prostate specific antigen cannot distinguish stage T1a (A1) prosate cancer from benign prostatic hyperplasia. J Urol 151 : 1291-1295, 1994
6. Lepor H, Wang B and Shapiro E : Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urol 44 : 199-205, 1994
7. Benson MC, Ring KS and Olsson CA : Determination of stage D-0 carcinoma of the prostate using PSA density. Urologist's Correspondence Club, September 24, 1989
8. Shinohara K, Wolf JS, Narayan P, et al.: Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol 152 : 120-123, 1994
9. Bazinet M, Mershref AW, Trudel C, et al.: Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostate carcinoma. Urol 43 : 44-51, 1994
10. Arai Y, Maeda H, Ishitoya S. et al.: Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examination and intermediate prostate specific antigen. J Urol 158 : 861, 1997
11. Stamey TA, Dietrick DD and Issa MM : Large, organ confined, impalpable transition zone prostate cancer : association with metastatic levels of prostate specific antigen. J Urol 149 : 510-515, 1993
12. Catalona WJ, Richie JP, DeKernion JB, et al.: Comparison of prostate specific antigen concentration and prostate specific antigen density in early detection of prostate cancer : receiver operating characteristics curves. J Urol 152 : 2031-2036, 1994